4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway.

MLA

Wang, Xu-Na, et al. “4-Hydroxybenzoic Acid (4-HBA) Enhances the Sensitivity of Human Breast Cancer Cells to Adriamycin as a Specific HDAC6 Inhibitor by Promoting HIPK2/P53 Pathway.” Biochemical & Biophysical Research Communications, vol. 504, no. 4, Oct. 2018, pp. 812–19. EBSCOhost, https://doi.org/10.1016/j.bbrc.2018.08.043.

APA

Wang, X.-N., Wang, K.-Y., Zhang, X.-S., Yang, C., & Li, X.-Y. (2018). 4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway. Biochemical & Biophysical Research Communications, 504(4), 812–819. https://doi.org/10.1016/j.bbrc.2018.08.043

Chicago

Wang, Xu-Na, Kui-Yang Wang, Xue-Song Zhang, Chao Yang, and Xue-Ying Li. 2018. “4-Hydroxybenzoic Acid (4-HBA) Enhances the Sensitivity of Human Breast Cancer Cells to Adriamycin as a Specific HDAC6 Inhibitor by Promoting HIPK2/P53 Pathway.” Biochemical & Biophysical Research Communications 504 (4): 812–19. doi:10.1016/j.bbrc.2018.08.043.